OVIT (OncoVista Innovative Therapies) Scaled Net Operating Assets: -220.43 (As of Sep. 2015)


What is OncoVista Innovative Therapies Scaled Net Operating Assets?

OncoVista Innovative Therapies OVIT Scaled Net Operating Assets is -220.43 as of Sep. 2015.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OncoVista Innovative Therapies's operating assets for the quarter that ended in Sep. 2015 was $0.00 Mil. OncoVista Innovative Therapies's operating liabilities for the quarter that ended in Sep. 2015 was $6.17 Mil. OncoVista Innovative Therapies's Total Assets for the quarter that ended in Jun. 2015 was $0.03 Mil. Therefore, OncoVista Innovative Therapies's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2015 was -220.43.

OncoVista Innovative Therapies Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Scaled Net Operating Assets Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.21 -0.59 -1.00 -5.50 -56.96

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.64 -45.95 -436.46 -118.82 -220.43

OVIT vs RSPI, HSTC, CAPS: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, OncoVista Innovative Therapies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's Scaled Net Operating Assets falls into.


OncoVista Innovative Therapies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OncoVista Innovative Therapies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2014 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2014 )
=(Operating Assets (A: Dec. 2014 )-Operating Liabilities (A: Dec. 2014 ))/Total Assets (A: Dec. 2013 )
=(0-5.468)/0.096
=-56.96

where

Operating Assets(A: Dec. 2014 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.013 - 0.013
=0

Operating Liabilities(A: Dec. 2014 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=5.676 - 0 - 0.208
=5.468

OncoVista Innovative Therapies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2015 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2015 )
=(Operating Assets (Q: Sep. 2015 )-Operating Liabilities (Q: Sep. 2015 ))/Total Assets (Q: Jun. 2015 )
=(0-6.172)/0.028
=-220.43

where

Operating Assets(Q: Sep. 2015 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.061 - 0.061
=0

Operating Liabilities(Q: Sep. 2015 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6.651 - 0 - 0.479
=6.172

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -220.43 mean?
OncoVista Innovative Therapies (OVIT) has a Scaled Net Operating Assets of -220.43 as of Sep. 2015. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Scaled Net Operating Assets too high?
OncoVista Innovative Therapies' current Scaled Net Operating Assets is -220.43.
How does OncoVista Innovative Therapies' Scaled Net Operating Assets compare to RSPI and HSTC?
OncoVista Innovative Therapies' Scaled Net Operating Assets of -220.43 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Scaled Net Operating Assets is -220.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Scaled Net Operating Assets of -220.43. The current Scaled Net Operating Assets is -220.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Scaled Net Operating Assets is -220.43 as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.